Kiadis Pharma Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Amsterdam, NH Netherlands
Total Funding:N/A
Industry:Biotech
Founded:1997
Lead Investor(s):N/A
Press
Claim your profile

Industry Ranking

Estimated Revenue & Financials

  • Kiadis Pharma's estimated annual revenue is currently $30.7M per year.
  • Kiadis Pharma's estimated revenue per employee is $155,000

Employee Data

  • Kiadis Pharma has 198 Employees.
  • Kiadis Pharma grew their employee count by 77% last year.
  • Kiadis Pharma currently has 7 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Kiadis Pharma
$30.7M19877%N/A
Adimab
$16.6M1076%N/A
Mascoma
$9.5M619%N/A
M2S
$22.3M144N/AN/A
Catalyze
$19.4M12536%N/A
LSNE Contract M...
$50.7M32713%N/A
Missing a competitor? Contribute!?
Submit

Kiadis Pharma is a clinical stage biopharmaceutical company focused on research, development and future commercialisation of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. Kiadis Pharma is committed to developing innovative and potentially life'saving therapies for patients with late-stage blood cancers and patients with inherited blood disorders, who are in need of a transplant, an area of significant unmet medical need.

keywords:N/A

198

Number of Employees

$30.7M

Revenue (est)

7

Current Jobs

77%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Maryann CiminoManager, Investor Relations & Corporate Affairs
Scott HolmesChief Financial Officer
Robert IgarashiVice President Of Discovery And Pre-clinical Development
Marcia BlackmooreAssociate Director
Andrew SandlerChief Medical Officer
Amy SullivanSvp, Corporate Affairs

Kiadis Pharma News

12-Sep-19 - Kiadis Pharma announces results for the six months ended June 30, 2019

Arthur Lahr, CEO of Kiadis Pharma, commented: “In the first six months of 2019, through the acquisition of Cytosen, we have transformed Kiadis ...

17-Aug-19 - Kiadis Pharma Announces Investor Events for September ...

Company announces Notice of Results for the six months ended June 30, 2019. Amsterdam, The Netherlands, August 19, 2019 – Kiadis ...

12-Sep-19 - Kiadis Pharma N.V. (KIADF) CEO Arthur Lahr On Q2 2019 Results - Earnings Call Transcript

Kiadis Pharma N.V. (OTC:KIADF) Q2 2019 Earnings Conference Call September 10, 2019 9:00 AM ET. Company Participants. Amy Sullivan ...